News
ZYBT
0.8910
+3.13%
0.0270
Weekly Report: what happened at ZYBT last week (0601-0605)?
Weekly Report · 1d ago
Zhengye Biotechnology receives deficiency notice over minimum bid price
TipRanks · 5d ago
Zhengye Biotechnology Faces Nasdaq Minimum Bid Price Deficiency After May 29 Notice
TipRanks · 5d ago
Zhengye Biotechnology Receives Nasdaq Listing Notice Of Failure To Maintain Minimum Bid Pricing Requirements
Benzinga · 5d ago
Zhengye Biotechnology receives Nasdaq notice for US$ 1 minimum bid price deficiency
PUBT · 5d ago
Zhengye Biotechnology gets Nasdaq notice for US$ 1 minimum bid price deficiency
PUBT · 5d ago
ZHENGYE BIOTECHNOLOGY HOLDING LIMITED RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM BID PRICE DEFICIENCY
Reuters · 5d ago
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Barchart · 5d ago
Weekly Report: what happened at ZYBT last week (0525-0529)?
Weekly Report · 06/01 09:12
Weekly Report: what happened at ZYBT last week (0518-0522)?
Weekly Report · 05/25 09:12
Weekly Report: what happened at ZYBT last week (0511-0515)?
Weekly Report · 05/18 09:12
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 05/11 12:06
Weekly Report: what happened at ZYBT last week (0504-0508)?
Weekly Report · 05/11 09:12
Weekly Report: what happened at ZYBT last week (0427-0501)?
Weekly Report · 05/04 09:11
Zhengye Biotech FY25 net loss widens to RMB 83 million; revenue drops 37.6% to RMB 116.4 million
PUBT · 04/28 21:05
Zhengye Biotechnology GAAP EPS of -$0.21, revenue of $16.6M
Seeking Alpha · 04/28 21:00
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results
PR Newswire · 04/28 20:30
Weekly Report: what happened at ZYBT last week (0420-0424)?
Weekly Report · 04/27 09:12
Zhengye Biotechnology files Form 3 for director Hu Qiyi
PUBT · 04/24 22:40
More
Webull provides a variety of real-time ZYBT stock news. You can receive the latest news about Zhengye Biotechnology Holding Limited through multiple platforms. This information may help you make smarter investment decisions.
About ZYBT
Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.